1. Coupling of Homologous Recombination and the Checkpoint by ATR.
- Author
-
Buisson R, Niraj J, Rodrigue A, Ho CK, Kreuzer J, Foo TK, Hardy EJ, Dellaire G, Haas W, Xia B, Masson JY, and Zou L
- Subjects
- Ataxia Telangiectasia Mutated Proteins genetics, Ataxia Telangiectasia Mutated Proteins metabolism, BRCA1 Protein genetics, BRCA1 Protein metabolism, Cyclin-Dependent Kinases genetics, Cyclin-Dependent Kinases metabolism, Fanconi Anemia Complementation Group N Protein, HeLa Cells, Humans, Nuclear Proteins genetics, Nuclear Proteins metabolism, Phosphorylation, Protein Binding, Signal Transduction, Time Factors, Tumor Suppressor Proteins genetics, Tumor Suppressor Proteins metabolism, DNA Breaks, Double-Stranded, Recombinational DNA Repair
- Abstract
ATR is a key regulator of cell-cycle checkpoints and homologous recombination (HR). Paradoxically, ATR inhibits CDKs during checkpoint responses, but CDK activity is required for efficient HR. Here, we show that ATR promotes HR after CDK-driven DNA end resection. ATR stimulates the BRCA1-PALB2 interaction after DNA damage and promotes PALB2 localization to DNA damage sites. ATR enhances BRCA1-PALB2 binding at least in part by inhibiting CDKs. The optimal interaction of BRCA1 and PALB2 requires phosphorylation of PALB2 at S59, an ATR site, and hypo-phosphorylation of S64, a CDK site. The PALB2-S59A/S64E mutant is defective for localization to DNA damage sites and HR, whereas the PALB2-S59E/S64A mutant partially bypasses ATR for its localization. Thus, HR is a biphasic process requiring both high-CDK and low-CDK periods. As exemplified by the regulation of PALB2 by ATR, ATR promotes HR by orchestrating a "CDK-to-ATR switch" post-resection, directly coupling the checkpoint to HR., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF